|
|
|
Direxion S&P Biotech Bear 3X 
|
33.45 0.39 (0.01%) |
04-20 15:59 |
Open: |
33.18 |
Pre close: |
33.06 |
Target:
|
284.21
|
High: |
33.9 |
Low: |
32.551 |
Resistance:
|
243.33
375.00
|
Volume: |
807,703 |
Market Cap: |
0M |
Support:
|
30.31
25.22
|
|
|
|
Technical Analysis |
Moving Averages |
MA(5):
|
32.54
 |
MACD |
MACD(12,26):
|
-63.08  |
MA(20): |
83.35  |
Signal(12,26,9): |
-68.76  |
MA(100): |
332.45  |
Stochastic Oscillator |
%K(14,3):
|
18.43  |
MA(250): |
537.19  |
%D(3): |
10.60  |
Average Volume(K) |
3-Month: |
39868
|
52-Week |
High:
|
1132.00 |
10-Days: |
115770 |
Low: |
30.31 |
RSI |
RSI(14):
|
25.24  |
Change(%): |
-96.8 |
Financials, Statistics and Valuation |
EPS |
0.000 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
27.95 |
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
0.0 |
Shares Float (M) |
27.95 |
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.00 |
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|